Separation of metabolic supply and demand: aerobic glycolysis as a normal physiological response to fluctuating energetic demands in the membrane

Tamir Epstein, Liping Xu, Robert J. Gillies, +1

Cancer & Metabolism

The harsh microenvironment in early breast cancer selects for a Warburg phenotype

Mehdi Damaghi, Jeffrey West, Mark Robertson‐Tessi, +10

Proceedings of the National Academy of Sciences

Intermittent Hypoxia Selects for Genotypes and Phenotypes That Increase Survival, Invasion, and Therapy Resistance

Daniel Verduzco, Mark C. Lloyd, Liping Xu, +4

PLoS ONE

GeneticsGenetic EpidemiologyFixed HypoxiaCancer BiologyTumor Biology +19

Heterobivalent ligands target cell-surface receptor combinations in vivo

Liping Xu, J.S. Josan, Josef Vágner, +6

Proceedings of the National Academy of Sciences

Drug TargetTumor BiologySynthetic HtmvlsSynthetic ImmunologyBivalent Htmvls +14

Heterobivalent Ligands Crosslink Multiple Cell‐Surface Receptors: The Human Melanocortin‐4 and δ‐Opioid Receptors

Josef Vágner, Liping Xu, Heather L. Handl, +5

Angewandte Chemie International Edition

Drug TargetSynthetic HeterobivalentPeptide SciencePharmacotherapyMolecular Pharmacology +21

The complete nucleotide sequence of the mitochondrial genome of the oriental fruit fly, Bactrocera dorsalis (Diptera: Tephritidae)

Dongsheng Yu, Liping Xu, Francesco Nardi, +2

Gene

BiologyPhylogeneticsMolecular EcologyGenome StudyComparative Genomics +12

Gold Nanorods Targeted to Delta Opioid Receptor: Plasmon-Resonant Contrast and Photothermal Agents

Kvar C. L. Black, Nathaniel D. Kirkpatrick, Timothy S. Troutman, +6

Molecular Imaging

<i>ScMT2-1-3</i>, a Metallothionein Gene of Sugarcane, Plays an Important Role in the Regulation of Heavy Metal Tolerance/Accumulation

Jinlong Guo, Liping Xu, Yachun Su, +4

BioMed Research International

Cell-Specific Targeting by Heterobivalent Ligands

J.S. Josan, Heather L. Handl, Rajesh Sankaranarayanan, +6

Bioconjugate Chemistry

Peptide ScienceImmunotherapeuticsTumor BiologyHeterobivalent LigandsMolecular Pharmacology +14

Enhanced targeting with heterobivalent ligands

Liping Xu, Josef Vágner, J.S. Josan, +7

Molecular Cancer Therapeutics